Clinical Trials on DCIS in Spain

Total 3 results

Fidia Farmaceutici s.p.a.

Completed

Study of ONCOFID-P-B™ (PACLITAXEL-HYALURONIC ACID)

Bladder Carcinoma in Situ (CIS)

Spain, Italy
GeNeuro Innovation SAS

Completed

Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease (LOMBARD)

Multiple Sclerosis (MS) | Clinically Isolated Syndrome (CIS) | Secondary Progressive MS | Primary Progressive MS | Relapsing-Remitting MS

France, Spain, Switzerland
Fidia Farmaceutici s.p.a.

Recruiting

Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)

Bladder Carcinoma in Situ (CIS)

United States, Spain, Italy, France, Poland

3

Subscribe